when do glp 1 side effects subside Ozempic and GLP-1 Drugs: Risk of Severe GLP-1 receptor agonists | How

Some patients find that evening dosing helps them manage daytime nausea, whilst others find morning administration allows them to eat lighter evening meals, which may further support weight management goals

In December 2024, the FDA approved tirzepatide (Zepbound) to treat moderate to severe obstructive sleep apnea in adults with obesity

Reasons for Discontinuing GLP-1 Use Lapsed weight loss users said price and insurance coverage were the top reasons for discontinuing use

In head-to-head weight-loss trials, tirzepatide produces slightly greater weight loss than semaglutide on average

Now, the FDA has announced a timeline for when most compounded versions may no longer be made